Skip to main content
Top
Published in: Clinical Rheumatology 4/2022

01-04-2022 | Fibromyalgia | Original Article

Clinical and psychological assessment of patients with rheumatoid arthritis and fibromyalgia: a real-world study

Authors: Chao Gao, Hua Zhong, Lihong Chen, Li Wang, Hong Yao, Xiaowei Huang, Yubo Jia, Chun Li, Tian Liu

Published in: Clinical Rheumatology | Issue 4/2022

Login to get access

Abstract

Objectives

To assess the clinical features and functional and psychological status of patients with rheumatoid arthritis (RA) and those with fibromyalgia (FM) in a real-world setting.

Method

Between December 2018 and April 2019, 202 inpatients with RA were enrolled from the Rheumatology and Immunology Department at Peking University People’s Hospital and assessed for the presence of FM using the 1990 American College of Rheumatology’s classification criteria for FM. Disease activity and functional and psychological status were assessed using the Disease Activity Score in 28 joints (DAS-28), Short-Form 36 (SF-36), Health Assessment Questionnaire (HAQ), Hospital Anxiety and Depression Scale, and Visual Analog Scale.

Results

Among the patients with RA, 42 (20.8%) had concurrent FM. Compared with patients without FM, patients with FM had higher DAS-28 (6.0 vs. 4.4, P = 0.011) and notably higher tender joint counts (16.5 vs. 4.5, P < 0.001). Patients with RA and FM had worse HAQ scores (1.24 vs. 0.66, P < 0.001) and lower SF-36 scores (28.6 vs. 58.2, P < 0.001). Patients with RA and FM experienced more fatigue (88.1% vs. 50.6%, P < 0.001) and had higher anxiety (10 vs. 4, P < 0.001) and depression scores (12 vs. 6, P < 0.001). No significant differences in erythrocyte sedimentation rate, C-reactive protein concentration, morning stiffness period, or swollen joint counts were found between the groups.

Conclusions

Patients with RA and FM had higher disease activity, a worse functional and psychological status, and poorer quality of life. The DAS-28 may have been overestimated in these patients. When patients with RA do not reach remission, FM should be considered.
Key Points
• Patients with rheumatoid arthritis and fibromyalgia had a worse functional and psychological status compared with those with rheumatoid arthritis alone.
• When patients with rheumatoid arthritis do not reach remission, fibromyalgia should be considered.
• Physicians should avoid overtreatment and enable these patients to receive the treatment, such as non-drug interventions, that they need.
Literature
1.
go back to reference Abbasi L, Haidri FR (2014) Fibromyalgia complicating disease management in rheumatoid arthritis. J Coll Physicians Surg Pak 24:424–427PubMed Abbasi L, Haidri FR (2014) Fibromyalgia complicating disease management in rheumatoid arthritis. J Coll Physicians Surg Pak 24:424–427PubMed
2.
3.
go back to reference Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28CrossRef Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28CrossRef
4.
go back to reference Wolfe F, Clauw DJ, Fitzcharles MA et al (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 38:1113–1122CrossRef Wolfe F, Clauw DJ, Fitzcharles MA et al (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol 38:1113–1122CrossRef
5.
go back to reference Wolfe F, Häuser W, Hassett AL, Katz RS, Walitt BT (2011) The development of fibromyalgia: examination of rates and predictors in patients with rheumatoid arthritis (RA). Pain 152:291–299CrossRef Wolfe F, Häuser W, Hassett AL, Katz RS, Walitt BT (2011) The development of fibromyalgia: examination of rates and predictors in patients with rheumatoid arthritis (RA). Pain 152:291–299CrossRef
6.
go back to reference Vincent A, Lahr BD, Wolfe F et al (2013) Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken) 65:786–792CrossRef Vincent A, Lahr BD, Wolfe F et al (2013) Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester Epidemiology Project. Arthritis Care Res (Hoboken) 65:786–792CrossRef
7.
go back to reference Joharatnam N, Mcwilliams DF, Wilson D, Wheeler M, Pande I, Walsh DA (2015) A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther 17:11CrossRef Joharatnam N, Mcwilliams DF, Wilson D, Wheeler M, Pande I, Walsh DA (2015) A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther 17:11CrossRef
8.
go back to reference Kiliçarslan A, Yurdakul FG, Bodur H (2018) Diagnosing fibromyalgia in rheumatoid arthritis: the importance of assessing disease activity. Turk J Phys Med Rehab 64:133–139CrossRef Kiliçarslan A, Yurdakul FG, Bodur H (2018) Diagnosing fibromyalgia in rheumatoid arthritis: the importance of assessing disease activity. Turk J Phys Med Rehab 64:133–139CrossRef
9.
go back to reference Ulus Y, Akyol Y, Tander B, Durmus D, Bilgici A, Kuru O (2011) Sleep quality in fibromyalgia and rheumatoid arthritis: associations with pain, fatigue, depression, and disease activity. Clin Exp Rheumatol 29(6 Suppl 69):S92–S96PubMed Ulus Y, Akyol Y, Tander B, Durmus D, Bilgici A, Kuru O (2011) Sleep quality in fibromyalgia and rheumatoid arthritis: associations with pain, fatigue, depression, and disease activity. Clin Exp Rheumatol 29(6 Suppl 69):S92–S96PubMed
10.
go back to reference Wolfe F, Michaud K (2004) Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol 31:695–700PubMed Wolfe F, Michaud K (2004) Severe rheumatoid arthritis (RA), worse outcomes, comorbid illness, and sociodemographic disadvantage characterize RA patients with fibromyalgia. J Rheumatol 31:695–700PubMed
11.
go back to reference Pollard LC, Kingsley GH, Choy EH, Scott DL (2010) Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology (Oxford) 49:924–928CrossRef Pollard LC, Kingsley GH, Choy EH, Scott DL (2010) Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology (Oxford) 49:924–928CrossRef
12.
go back to reference Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172CrossRef Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 33:160–172CrossRef
13.
go back to reference Mu R, Li C, Zhu JX et al (2013) National survey of knowledge, attitude and practice of fibromyalgia among rheumatologists in China. Int J Rheum Dis 16:258–263CrossRef Mu R, Li C, Zhu JX et al (2013) National survey of knowledge, attitude and practice of fibromyalgia among rheumatologists in China. Int J Rheum Dis 16:258–263CrossRef
14.
go back to reference Queiroz LP (2013) Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 17:356CrossRef Queiroz LP (2013) Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 17:356CrossRef
15.
go back to reference Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO (2018) Fibromyalgia remains a significant burden in rheumatoid arthritis in Australia. Int J Rheum Dis 21:639–646CrossRef Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO (2018) Fibromyalgia remains a significant burden in rheumatoid arthritis in Australia. Int J Rheum Dis 21:639–646CrossRef
16.
go back to reference Kim H, Cui J, Frits M et al (2017) Fibromyalgia predicts two-year changes in functional status in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 69:1871–1877CrossRef Kim H, Cui J, Frits M et al (2017) Fibromyalgia predicts two-year changes in functional status in rheumatoid arthritis patients. Arthritis Care Res (Hoboken) 69:1871–1877CrossRef
17.
go back to reference Macfarlane GJ, Kronisch C, Dean LE et al (2017) EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 76:318–328CrossRef Macfarlane GJ, Kronisch C, Dean LE et al (2017) EULAR revised recommendations for the management of fibromyalgia. Ann Rheum Dis 76:318–328CrossRef
Metadata
Title
Clinical and psychological assessment of patients with rheumatoid arthritis and fibromyalgia: a real-world study
Authors
Chao Gao
Hua Zhong
Lihong Chen
Li Wang
Hong Yao
Xiaowei Huang
Yubo Jia
Chun Li
Tian Liu
Publication date
01-04-2022
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 4/2022
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-021-06026-6

Other articles of this Issue 4/2022

Clinical Rheumatology 4/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.